Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo
Quan Yuan(China Medical University), Li Sun(First Affiliated Hospital of Liaoning Medical University), Xiaoyu Song(China Medical University), Jianhua Chen(Hunan Cancer Hospital), Honghao Yu(Tongji Hospital)
Cited by 21
Related Papers
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
|Journal of Thoracic Oncology|2021|311
Ferroptosis, a new target for treatment of renal injury and fibrosis in a 5/6 nephrectomy-induced CKD rat model
|Cell Death Discovery|2022|144
Exosomes: The emerging mechanisms and potential clinical applications in dermatology
|International Journal of Biological Sciences|2024|72
Puerarin Alleviates UUO-Induced Inflammation and Fibrosis by Regulating the NF-κB P65/STAT3 and TGFβ1/Smads Signaling Pathways
|Drug Design Development and Therapy|2021|49
Current landscape of personalized clinical treatments for triple-negative breast cancer
|Frontiers in Pharmacology|2022|44